Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?

A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagogo-Jack, Ibiayi, Shaw, Alice T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912373/
https://www.ncbi.nlm.nih.gov/pubmed/27245570
http://dx.doi.org/10.1634/theoncologist.2016-0179
_version_ 1782438260267548672
author Dagogo-Jack, Ibiayi
Shaw, Alice T.
author_facet Dagogo-Jack, Ibiayi
Shaw, Alice T.
author_sort Dagogo-Jack, Ibiayi
collection PubMed
description A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welcome addition to the current screening repertoire.
format Online
Article
Text
id pubmed-4912373
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-49123732016-06-24 Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics? Dagogo-Jack, Ibiayi Shaw, Alice T. Oncologist Commentary A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welcome addition to the current screening repertoire. AlphaMed Press 2016-06 2016-05-31 /pmc/articles/PMC4912373/ /pubmed/27245570 http://dx.doi.org/10.1634/theoncologist.2016-0179 Text en ©AlphaMed Press
spellingShingle Commentary
Dagogo-Jack, Ibiayi
Shaw, Alice T.
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title_full Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title_fullStr Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title_full_unstemmed Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title_short Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
title_sort screening for alk rearrangements in lung cancer: time for a new generation of diagnostics?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912373/
https://www.ncbi.nlm.nih.gov/pubmed/27245570
http://dx.doi.org/10.1634/theoncologist.2016-0179
work_keys_str_mv AT dagogojackibiayi screeningforalkrearrangementsinlungcancertimeforanewgenerationofdiagnostics
AT shawalicet screeningforalkrearrangementsinlungcancertimeforanewgenerationofdiagnostics

Ejemplares similares